Esperance Pharmaceuticals' Series B Round

Esperance Pharmaceuticals raised a round of funding on June 01, 2011.

Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.…

Articles about Esperance Pharmaceuticals' Series B Round: